Ronghua Yang
Newark, NJNPI 1588198121
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Biotronik Inc. at 29.5% of the total. Reporting peaked in 2024 at $17,602 and has fallen 53.2% since, to $8,230 in 2025.
Across 227 payments — averaging $165.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$11K
- Boston Scientific$11K
- Medtronic$8K
- Abbott$6K
- Philips North America LLC$1K
- Biosense Webster, Inc.$1K
- plus $512 from 3 others
What the payments were for
- Grants$5,56515%
- Travel & lodging$20,44654%
- Food & beverage$11,00429%
- Education$6642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 67 | $11,128 |
| Boston Scientific | 35 | $10,510 |
| Medtronic | 55 | $7,513 |
| Abbott | 43 | $5,888 |
| Philips North America LLC | 8 | $1,093 |
| Biosense Webster, Inc. | 14 | $1,035 |
| Medical Device Business Services, Inc. | 3 | $383 |
| AstraZeneca | 1 | $99 |
| Merck | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$3,181
- VersaCross Access Solution$1,866
- WATCHMAN Access System$1,385
- ENSITE$1,027
- Carto 3$914
- Acticor 7 VR-T DX$776
- BioMonitor$695
- Edora 8 DR-T$547
- Solia$547
- Rivacor 7 DR-T$547
- (9124) LM Undivided$474
- (9520) IGT Devices Undivided$410
- Micra$407
- NUVISION ICE CATHETER$341
- EMBLEM MRI S-ICD$270
- AMVIA EDGE$108
- OCTARAY MAPPING CATHETER$101
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $34,726 |
| Amiodarone Hcl | 21 | $1,391 |
| Metoprolol Succinate | 26 | $603 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.